Prostate Cancer Risk Assessment and Robotic Radical Prostatectomy - Research on Aging

Prostate Cancer Risk Assessment and Robotic Radical Prostatectomy - Research on Aging

First Aired: 5/8/2008

Length: 53 minutes


SIRA: Prostate Cancer Risk Assessment
 
Our PriceUS$24.95
ShopID14199
 


National recognized expert, Christopher Kane, MD, Urology Chief, UCSD Medical Center, reviews Prostate Cancer epidemiology and risk assessment information such as serum PSA, clinical stage, Gleason grade and biopsy information. He also reviews the stage and risk migration that has occurred throughout the PSA era. Finally, Dr. Kane reviewed robotic radical prostatectomy and how this exciting new technology is applied to prostate cancer surgery.
No recommended products at the moment.